1. Home
  2. STXS vs VIGL Comparison

STXS vs VIGL Comparison

Compare STXS & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • VIGL
  • Stock Information
  • Founded
  • STXS 1990
  • VIGL 2020
  • Country
  • STXS United States
  • VIGL United States
  • Employees
  • STXS N/A
  • VIGL N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • STXS Health Care
  • VIGL Health Care
  • Exchange
  • STXS Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • STXS 151.3M
  • VIGL 134.9M
  • IPO Year
  • STXS 2004
  • VIGL 2022
  • Fundamental
  • Price
  • STXS $2.17
  • VIGL $7.96
  • Analyst Decision
  • STXS
  • VIGL Buy
  • Analyst Count
  • STXS 0
  • VIGL 7
  • Target Price
  • STXS N/A
  • VIGL $8.00
  • AVG Volume (30 Days)
  • STXS 270.0K
  • VIGL 1.5M
  • Earning Date
  • STXS 08-11-2025
  • VIGL 08-12-2025
  • Dividend Yield
  • STXS N/A
  • VIGL N/A
  • EPS Growth
  • STXS N/A
  • VIGL N/A
  • EPS
  • STXS N/A
  • VIGL N/A
  • Revenue
  • STXS $27,510,000.00
  • VIGL N/A
  • Revenue This Year
  • STXS $25.90
  • VIGL N/A
  • Revenue Next Year
  • STXS $60.57
  • VIGL N/A
  • P/E Ratio
  • STXS N/A
  • VIGL N/A
  • Revenue Growth
  • STXS 1.50
  • VIGL N/A
  • 52 Week Low
  • STXS $1.54
  • VIGL $1.31
  • 52 Week High
  • STXS $2.72
  • VIGL $7.96
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.27
  • VIGL 88.44
  • Support Level
  • STXS $2.00
  • VIGL $7.86
  • Resistance Level
  • STXS $2.36
  • VIGL $7.90
  • Average True Range (ATR)
  • STXS 0.11
  • VIGL 0.03
  • MACD
  • STXS -0.01
  • VIGL -0.20
  • Stochastic Oscillator
  • STXS 50.00
  • VIGL 91.67

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

Share on Social Networks: